Share. Connect. Create. Grow. · Socialiya
AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core b...

BUSINESS NEWS June 22, 2026

AbbVie to Buy Immunology Drugmaker Apogee for $10.9 Billion

Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core business.

7 views 0 likes 0 comments
Share:
Deal adds an experimental drug for moderate to severe atopic dermatitis, building up AbbVie's core business.

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement